GlassScriptPhysician profile
Natalie Mota
NPI 1962817916
$1,243.82
in general payments reported to CMS, 2019-2025
17 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $61.01 · 2021: $183 · 2022: $48.89 · 2023: $49.43 · 2024: $410 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $352.00 | 2021-2025 | Affinity, Cygnus Dual, Puraply Wound Matrix |
| Stryker Corporation | $291.30 | 2019-2022 | |
| Kerecis Limited | $88.72 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $68.36 | 2023-2025 | Stravix, Collagenase Santyl, Grafix Pl |
| Integra Lifesciences Corporation | $65.94 | 2019-2022 | |
| Celularity INC. | $62.00 | 2019 | |
| Polynovo North America LLC | $47.78 | 2024 | Novosorb Btm |
| Paragon 28, INC. | $41.27 | 2021-2022 | |
| Medtronic, INC. | $41.22 | 2023-2025 | Inceptiv, Vanta Adaptivestim |
| Treace Medical Concepts, INC. | $36.05 | 2024-2025 | |
| Solventum Corporation | $27.65 | 2025 | Activ.A.C. |
| Misonix INC | $26.80 | 2020-2021 | |
| Axogen | $21.78 | 2025 | |
| Acera Surgical, INC. | $21.54 | 2021 | |
| Elite Orthopedics, LLC | $18.38 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $17.81 | 2024 | Qutenza |
| Zimmer Biomet Holdings, INC. | $15.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Mota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.